These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18523733)

  • 1. Clinical pharmacology of gold.
    Kean WF; Kean IR
    Inflammopharmacology; 2008 Jun; 16(3):112-25. PubMed ID: 18523733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of auranofin: overview and update.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1986; 63():19-28. PubMed ID: 3110942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The pharmacology of gold compounds].
    Juan H
    Wien Klin Wochenschr Suppl; 1984; 156():7-13. PubMed ID: 6442062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold therapy. II. Historical, chemical, pharmacological and biological profile of anti-arthritic gold compounds.
    Kean WF; Gerecz E; Hogan MG
    Singapore Med J; 1987 Apr; 28(2):117-25. PubMed ID: 3155422
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of longterm treatment with auranofin and gold sodium thiomalate on immune function in the dog.
    Bloom JC; Thiem PA; Halper LK; Saunders LZ; Morgan DG
    J Rheumatol; 1988 Mar; 15(3):409-17. PubMed ID: 3132555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to gold compounds.
    Cohen MA
    Adverse Drug React Acute Poisoning Rev; 1988; 7(4):163-78. PubMed ID: 3149142
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
    Iqbal MS; Saeed M; Taqi SG
    Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of action of gold compounds].
    Vischer TL
    Wien Klin Wochenschr Suppl; 1984; 156():17-8. PubMed ID: 6442050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paradox of gold compounds: activators or inhibitors?
    Parente JE; Wong K; Davis P
    J Rheumatol; 1986 Oct; 13(5):846-8. PubMed ID: 3102725
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications and contraindications for systemic gold therapy].
    Schattenkirchner M
    Wien Klin Wochenschr Suppl; 1984; 156():3-7. PubMed ID: 6442054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on methotrexate.
    Braun J; Rau R
    Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of parenteral and oral gold compounds.
    Gottlieb NL
    J Rheumatol Suppl; 1982; 8():99-109. PubMed ID: 6813498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auranofin-induced vasomotor reaction.
    Proudman SM; Cleland LG
    Arthritis Rheum; 1992 Dec; 35(12):1452-4. PubMed ID: 1472122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intracellular gold content of circulating blood cells using various gold compounds].
    Herrlinger JD; Beress R; Hecker U
    Wien Klin Wochenschr Suppl; 1984; 156():13-6. PubMed ID: 6442048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chrysotherapy on cell mediated immune response.
    Lorber A; Jackson WH; Simon TM
    J Rheumatol Suppl; 1982; 8():37-45. PubMed ID: 6813490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanisms of action of conventional chrysotherapy.
    Bluhm GB
    J Rheumatol Suppl; 1982; 8():10-7. PubMed ID: 6813472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarthritic synergism of combined oral and parenteral chrysotherapy. I. Studies in adjuvant-induced arthritis in rats.
    Finkelstein AE; Ladizesky M; Borinsky R; Kohn E; Ginsburg I
    Inflammation; 1988 Aug; 12(4):373-82. PubMed ID: 3139562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular versus oral gold therapy.
    Kean WF
    Baillieres Clin Rheumatol; 1990 Aug; 4(2):219-46. PubMed ID: 2032298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.